“…The sensitivity, specificity, and wide dynamic range for detection of low-abundance secreted peptides makes MS exceptionally well suited for profiling as well as the structural and quantitative characterization of the peptidome in various models, and enables further discovery of pharmacological targets. Secretomics studies, most often based on liquid chromatography-MS/MS technology, have been applied to the analysis of neuropeptides in releasates from cell and organ cultures, brain microdialysates, and cerebrospinal fluid (Bernay et al, 2009;Yin et al, 2012;Tillmaand et al, 2015;Gahoi and Gautam, 2016;Al-Hasani et al, 2018;Beumer et al, 2020;Royds et al, 2021).…”